The 2015 Winter Symposium, “Drug-Drug Interactions: What We Do and What Value it Adds” will be held February 19, 2015 at The Solutions Center in Research Triangle Park, NC. The draft program features several scientific leaders who will present key innovations and case studies covering pre-clinical and clinical approaches and predictive strategies to provide informative data earlier to reduce later risk in drug discovery and development programs.
Gerald Miwa, PhD: Topic Introduction
Christopher C. MacLauchlin, PhD - GSK: “Mechanisms of DDI and Preclinical Options”
Karen Rowland Yeo, PhD - Simcyp Limited (part of Certara): “How Do We Translate Preclinical and Clinical Research Into Labeling?”
Daniele Ouellet, PhD - GSK: “Drug-Drug Interactions – A Clinical Development Perspective”
Amanda H. Corbett, PharmD, BCPS, FCCP - UNC: “How Do We Use Drug Drug Interaction Information in the Clinical Setting?”
Keynote Speaker: Lawrence J. Lesko, PhD, FCP: “Are We Getting the Best Return on Investment from DDI Studies?”
Students and post-doctoral research associates: Submit your original research posters for presentation during the Symposium! This is a great way to gain visibility and to network with the community! The subject matter of posters need not be related to the Symposium topic. Travel awards of $500 and $250 will be awarded to two presenters of eligible posters (submission information and details).
Are you a company or vendor wishing to network with our members? Opportunities for sponsorship of the RTP DMDG and a display booth at our Winter Symposium are available. Contact firstname.lastname@example.org or email@example.com for more information.